{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:26:58Z","timestamp":1765254418106,"version":"3.32.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaad.2024.06.047","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T06:43:19Z","timestamp":1719643399000},"page":"706-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral smoothened inhibitors for Gorlin syndrome: A clinical review"],"prefix":"10.1016","volume":"91","author":[{"given":"Alexandra","family":"Baczynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Worley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2024.06.047_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1735-3327.92963","article-title":"Gorlin-Goltz syndrome","volume":"9","author":"Joshi","year":"2012","journal-title":"Dent Res J (Isfahan)"},{"issue":"18","key":"10.1016\/j.jaad.2024.06.047_bib2","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1158\/0008-5472.CAN-14-1666","article-title":"Sonic hedgehog signaling in Basal cell nevus syndrome","volume":"74","author":"Athar","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2024.06.047_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394622-5.00001-8","article-title":"Hedgehog signaling","volume":"88","author":"Choy","year":"2012","journal-title":"Vitam Horm"},{"issue":"2","key":"10.1016\/j.jaad.2024.06.047_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/cells8020153","article-title":"Targeting the hedgehog pathway in cancer: current evidence and future perspectives","volume":"8","author":"Girardi","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jaad.2024.06.047_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2217\/fon-2017-0457","article-title":"Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial","volume":"14","author":"Chen","year":"2018","journal-title":"Future Oncol"},{"issue":"23","key":"10.1016\/j.jaad.2024.06.047_bib6","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2024.06.047_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00403-024-03157-z","article-title":"Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome","volume":"316","author":"Lukowiak","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jaad.2024.06.047_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(17)30072-4","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dr\u00e9no","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2024.06.047_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/CCID.S233097","article-title":"Efficacy and safety of sonidegib in adult patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome): results from a phase 2, double-blind, randomized trial","volume":"13","author":"Lear","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.06.047_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15095","article-title":"Sonidegib after vismodegib discontinuation in a patient with Gorlin-Goltz syndrome and multiple basal cell carcinomas","volume":"34","author":"Piccerillo","year":"2021","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2024.06.047_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.25251\/skin.2.2.1","article-title":"L-Carnitine reduces muscle cramps in patients taking vismodegib","volume":"2","author":"Dinehart","year":"2018","journal-title":"SKIN"},{"issue":"7","key":"10.1016\/j.jaad.2024.06.047_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15531","article-title":"Sonidegib-induced muscle spasms in the treatment of basal cell carcinoma: strategies to adopt","volume":"35","author":"Villani","year":"2022","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.jaad.2024.06.047_bib13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamadermatol.2015.1937","article-title":"Effect of calcium channel blockade on vismodegib-induced muscle cramps","volume":"151","author":"Ally","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.06.047_bib14","first-page":"670","article-title":"Vismodegib (erivedge) for advanced Basal cell carcinoma","volume":"37","author":"Fellner","year":"2012","journal-title":"P T"},{"first-page":"1","year":"2015","series-title":"Odomzo (Sonidegib Capsules) Prescribing Information","key":"10.1016\/j.jaad.2024.06.047_bib15"},{"key":"10.1016\/j.jaad.2024.06.047_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582866","article-title":"Sonidegib for the treatment of advanced basal cell carcinoma","volume":"10","author":"Brancaccio","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2024.06.047_bib17","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1078-0432.CCR-16-2051","article-title":"FDA approval summary: sonidegib for locally advanced basal cell carcinoma","volume":"23","author":"Casey","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2024.06.047_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11864-019-0683-9","article-title":"Sonic hedgehog pathway inhibition in the treatment of advanced basal cell carcinoma","volume":"20","author":"Leavitt","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2024.06.047_bib19","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1111\/jdv.14844","article-title":"Levocarnitine for vismodegib-associated muscle spasms: a pilot randomized, double-blind, placebo-controlled, investigator-initiated trial","volume":"32","author":"Cannon","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2024.06.047_bib20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s13555-021-00588-8","article-title":"Key clinical adverse events in patients with advanced basal cell carcinoma treated with sonidegib or vismodegib: a post hoc analysis","volume":"11","author":"Gutzmer","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"11","key":"10.1016\/j.jaad.2024.06.047_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006442","article-title":"Maintenance of taste organs is strictly dependent on epithelial hedgehog\/GLI signaling","volume":"12","author":"Ermilov","year":"2016","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.jaad.2024.06.047_bib22","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00520-015-2932-1","article-title":"Dysgeusia and weight loss under treatment with vismodegib: benefit of nutritional management","volume":"24","author":"Le Moigne","year":"2016","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2024.06.047_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jdcr.2017.11.011","article-title":"Vismodegib-resistant basal cell carcinomas in basal cell nevus syndrome: clinical approach and genetic analysis","volume":"4","author":"Sinx","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"22","key":"10.1016\/j.jaad.2024.06.047_bib24","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.3390\/cancers13225706","article-title":"Treatment of advanced basal cell carcinoma with hedgehog pathway inhibitors: a multidisciplinary expert meeting","volume":"13","author":"De Giorgi","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224009770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224009770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:56:50Z","timestamp":1736301410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224009770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0190962224009770"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.06.047","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral smoothened inhibitors for Gorlin syndrome: A clinical review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}